MarketPulse

central nervous system

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Taysha Gene Therapies to Report Q1 2026 Results, Discuss Clinical Pipeline Progress

Taysha Gene Therapies will report Q1 2026 financial results and discuss TSHA-102 Rett syndrome program progress on May 6, 2026.
TSHAclinical-stagegene therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Relmada Therapeutics to Unveil Q4 2025 Results Amid $160M Funding Boost

Relmada Therapeutics to report Q4 2025 results March 19, 2026, following $160M oversubscribed fundraise and Leerink Partners conference presentation.
RLMDclinical-stage biotechprivate placement